Подписаться
Joakim Riikonen
Joakim Riikonen
Подтвержден адрес электронной почты в домене uef.fi - Главная страница
Название
Процитировано
Процитировано
Год
Mesoporous systems for poorly soluble drugs
W Xu, J Riikonen, VP Lehto
International journal of pharmaceutics 453 (1), 181-197, 2013
2522013
In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size
HA Santos, J Riikonen, J Salonen, E Mäkilä, T Heikkilä, T Laaksonen, ...
Acta biomaterialia 6 (7), 2721-2731, 2010
1992010
Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles
T Laaksonen, H Santos, H Vihola, J Salonen, J Riikonen, T Heikkilä, ...
Chemical research in toxicology 20 (12), 1913-1918, 2007
1762007
In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles
M Kilpeläinen, J Riikonen, MA Vlasova, A Huotari, VP Lehto, J Salonen, ...
Journal of Controlled Release 137 (2), 166-170, 2009
1462009
Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles
T Limnell, J Riikonen, J Salonen, AM Kaukonen, L Laitinen, J Hirvonen, ...
International journal of pharmaceutics 343 (1-2), 141-147, 2007
1362007
Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations
M Kaasalainen, E Mäkilä, J Riikonen, M Kovalainen, K Järvinen, ...
International journal of pharmaceutics 431 (1-2), 230-236, 2012
1012012
Surface chemistry, reactivity, and pore structure of porous silicon oxidized by various methods
J Riikonen, M Salomaki, J van Wonderen, M Kemell, W Xu, O Korhonen, ...
Langmuir 28 (28), 10573-10583, 2012
972012
Utilising thermoporometry to obtain new insights into nanostructured materials: review part 1
J Riikonen, J Salonen, VP Lehto
Journal of thermal analysis and calorimetry 105 (3), 811-821, 2011
962011
Determination of the physical state of drug molecules in mesoporous silicon with different surface chemistries
J Riikonen, E Makila, J Salonen, VP Lehto
Langmuir 25 (11), 6137-6142, 2009
912009
Novel delivery systems for improving the clinical use of peptides
M Kovalainen, J Mönkäre, J Riikonen, U Pesonen, M Vlasova, J Salonen, ...
Pharmacological reviews 67 (3), 541-561, 2015
822015
Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery
M Kilpeläinen, J Mönkäre, MA Vlasova, J Riikonen, VP Lehto, J Salonen, ...
European Journal of Pharmaceutics and Biopharmaceutics 77 (1), 20-25, 2011
762011
Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration
S Näkki, J Rytkönen, T Nissinen, C Florea, J Riikonen, P Ek, H Zhang, ...
Acta biomaterialia 13, 207-215, 2015
732015
Mesoporous systems for poorly soluble drugs–recent trends
J Riikonen, W Xu, VP Lehto
International journal of pharmaceutics 536 (1), 178-186, 2018
652018
Development of porous silicon nanocarriers for parenteral peptide delivery
M Kovalainen, J Monkare, M Kaasalainen, J Riikonen, VP Lehto, ...
Molecular Pharmaceutics 10 (1), 353-359, 2013
652013
Intraorally fast-dissolving particles of a poorly soluble drug: Preparation and in vitro characterization
R Laitinen, E Suihko, K Toukola, M Björkqvist, J Riikonen, VP Lehto, ...
European journal of pharmaceutics and biopharmaceutics 71 (2), 271-281, 2009
592009
Amine surface modifications and fluorescent labeling of thermally stabilized mesoporous silicon nanoparticles
W Xu, J Riikonen, T Nissinen, M Suvanto, K Rilla, B Li, Q Wang, F Deng, ...
The Journal of Physical Chemistry C 116 (42), 22307-22314, 2012
542012
Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib
J Riikonen, A Correia, M Kovalainen, S Näkki, M Lehtonen, J Leppänen, ...
Biomaterials 52, 44-55, 2015
482015
Synthesis and characterization of Al2O3 nanoparticles by flame spray pyrolysis (FSP)—Role of Fe ions in the precursor
LD Hafshejani, S Tangsir, H Koponen, J Riikonen, T Karhunen, U Tapper, ...
Powder technology 298, 42-49, 2016
412016
Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation
R Laitinen, E Suihko, M Bjorkqvist, J Riikonen, VP Lehto, K Jarvinen, ...
Drug development and industrial pharmacy 36 (5), 601-613, 2010
412010
Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery
E Korhonen, S Rönkkö, S Hillebrand, J Riikonen, W Xu, K Järvinen, ...
European Journal of Pharmaceutics and Biopharmaceutics 100, 1-8, 2016
392016
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20